Farther Finance Advisors
KLRA icon

Farther Finance Advisors’s Kailera Therapeutics KLRA Stock Holding History

Farther Finance Advisors’s Portfolio KLRA Stock Details KLRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.03K Buy
+90
New +$1.52K ﹤0.01% 5573

Other funds holding KLRA

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors's KLRA Position: Q3 2026 in Review

Farther Finance Advisors opened a new position in Kailera Therapeutics (KLRA) in Q3 2026: 90 shares worth $1.03K. The stake represents ﹤0.01% of the portfolio and ranks #5573 among its holdings.

7 funds tracked by Wall St. Rank hold KLRA as of Q3 2026.

  • Farther Finance Advisors held 90 shares of Kailera Therapeutics worth $1.03K as of Q3 2026.
  • Kailera Therapeutics was a new Farther Finance Advisors position in Q3 2026.
  • Kailera Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5573 holding.
  • 7 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.